WASHINGTON — Days after President Trump delivered a speech on prescription drug prices that was notably light on criticism of the pharmaceutical industry, his health secretary on Monday struck a far more aggressive tone, warning that the administration would be “turning on the pressure” on drug makers.
The American public, Health and Human Services Secretary Alex Azar said, deserves to know which companies are “gouging consumers.”
Azar suggested that Trump would be quick to call out individual drug companies in the future.
About the Author Reprints
